23 Jul 2026 07:04:01 ET │ 12 pages Flash | Thermo Fisher Scientific Inc. (TMO.N) 2Q26 Quick Take: Signs of Recovery with Healthy Organic Growth Beat CITI'S TAKE TMO posted healthy 2Q organic growth of +5% beating guidance of ~3% and FactSet consensus of 3.1%, with revenues of ~$12bn above consensus $11.7bn. Adj. GM was 41.4% (consensus of 41.5%) and adj. OPM was 22.8% (consensus of 22.2%) leading to adj. EPS of $6.03, ahead of guidance midpoint and consensus of $5.72 . By segment, LSS sales $2.82bn beat con ...